The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Adamyan L.V.

National medical research center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov;
Russian university of medicine

Alyasova A.V.

FSBEI HE «RosUniMed» of MOH of Russia

Pivazyan L.G.

National medical research center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov

Stepanian A.A.

Academia of Women’s Health and Endoscopic Surgery

Immunological aspects of endometriosis: pathophysiological mechanisms, diagnosis, autoimmunity, targeted therapy and modulation

Authors:

Adamyan L.V., Alyasova A.V., Pivazyan L.G., Stepanian A.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2024;30(2): 15‑31

DOI: 10.17116/repro20243002115

Read: 6156 times

Download PDF (RU)
Contact the author
Table of contents

IMMUNOLOGICAL ASPECTS OF ENDOMETRIOSIS: PATHOPHYSIOLOGICAL MECHANISMS, DIAGNOSIS, AUTOIMMUNITY, TARGETED THERAPY AND MODULATION
IMMUNOLOGICAL ASPECTS OF ENDOMETRIOSIS: PATHOPHYSIOLOGICAL MECHANISMS, DIAGNOSIS, AUTOIMMUNITY, TARGETED THERAPY AND MODULATION

To cite this article:

Adamyan LV, Alyasova AV, Pivazyan LG, Stepanian AA. Immunological aspects of endometriosis: pathophysiological mechanisms, diagnosis, autoimmunity, targeted therapy and modulation. Russian Journal of Human Reproduction. 2024;30(2):15‑31. (In Russ.)
https://doi.org/10.17116/repro20243002115

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Expe­rience with the use of amitriptyline for chro­nic pelvic pain asso­ciated with endo­metriosis. Russian Journal of Human Reproduction. 2025;(1):86-93
Obje­ctification of Pain in Patients with Endo­metriosis. (Literature review and own data). Russian Journal of Human Reproduction. 2025;(2):62-85
The role of macrophage pola­rization in the deve­lopment of endo­metriosis and the therapeutic pote­ntial of its modu­lation. Russian Journal of Human Reproduction. 2025;(3):20-33
Expe­rimental mode­ling and treatment of endo­metriosis using bovhyaluronidase azoximer in an animal model. Russian Journal of Human Reproduction. 2025;(4):26-40
Deep endo­metriosis — a comparative study of pain syndrome and the prevalence of clinical symptoms acco­rding to the #ENZIAN classification. Russian Journal of Human Reproduction. 2025;(4):96-101
Endo­metriosis-associated infe­rtility and the effi­cacy of dienogest. Russian Journal of Human Reproduction. 2025;(5):58-63
Socio-demographic portrait of a patient with endo­metriosis using arti­ficial inte­lligence (original mate­rial). Russian Journal of Human Reproduction. 2025;(5):84-88
Genome-Wide Asso­ciation Studies (GWAS) in Endo­metriosis: Gene­tic Mechanisms and Como­rbidity. Russian Journal of Human Reproduction. 2025;(6):35-45
Use of gona­dotropic releasing hormone agonists in hype­rplastic syndrome in gyne­cology. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):51-58
Expe­rience of using anti-adhesive barriers in colo­rectal rese­ctions in connection with deep infi­ltrative endo­metriosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):81-86
Abstract:

Endometriosis is a gynecological disease characterized by the presence of tissue with morphological and functional properties similar to the endometrium outside the uterine cavity. This pathology affects about 10% of women of reproductive age worldwide and currently has no established etiology. However, the hypothesis of immune dysfunction as the main cause of endometriosis is quite controversial among researchers around the world. It has now been established that patients with endometriosis experience dysfunction of the cellular and humoral immune systems, consisting of improper functioning of signaling pathways, an imbalance of pro-inflammatory and anti-inflammatory cytokines, impaired reception and intercellular interaction, activation of an autoimmune inflammatory response and tissue damage. In addition, it is known that these patients have polymorphism of genes responsible for the development of a number of autoimmune conditions, which, together with the fact of production of autoantibodies, indicates a possible connection between endometriosis and autoimmune pathologies. The purpose of the review is to summarize modern scientific data on the problem of immune dysregulation in the etiology of endometriosis and describe the abnormal immunological mechanisms involved in its pathogenesis, as well as to identify autoimmune conditions comorbid with endometriosis, to study the possibilities of using immunological and immunogenetic biomarkers for early non-invasive diagnosis of endometriosis and the possibility of targeted immunotherapy, immunomodulation for the purpose of further personalized approach to patient data management

Keywords:

endometriosis
etiology of endometriosis
immune dysregulation
immunogenetic biomarker

Authors:

Adamyan L.V.

National medical research center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov;
Russian university of medicine

Alyasova A.V.

FSBEI HE «RosUniMed» of MOH of Russia

Pivazyan L.G.

National medical research center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov

Stepanian A.A.

Academia of Women’s Health and Endoscopic Surgery

Received:

27.02.2024

Accepted:

15.03.2024

Close metadata

References:

  1. Endometrioz. Klinicheskie rekomendatsii. M.: Ministerstvo zdravooxraneniya Rossijskoj Federacii; 2020. Odobreno Nauchno-prakticheskim Sovetom Ministerstva zdravooxraneniya Rossijskoj Federacii. Accessed February 9, 2024. (In Russ.). https://minzdrav.samregion.ru/wp-content/uploads/sites/28/2020/12/endometrioz.pdf?ysclid=lfgnra6oc3298261126
  2. Chen S, Liu Y, Zhong Z, Wei C, Liu Y, Zhu X. Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives. Frontiers in Immunology. 2023;14:1134663. https://doi.org/10.3389/fimmu.2023.1134663
  3. Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertility and Sterility. 2019;111(2):327-340.  https://doi.org/10.1016/j.fertnstert.2018.10.013
  4. Koninckx PR, Ussia A, Adamyan L, Tahlak M, Keckstein J, Wattiez A, Martin DC. The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear. Best Practice and Research. Clinical Obstetrics and Gynaecology. 2021;71:1426. https://doi.org/10.1016/j.bpobgyn.2020.08.005
  5. Adamyan LV, Arslanyan KN, Loginova ON, Manukyan LM, Kharchenko EI. Immunological aspects of endometriosis: review of the literature. Lechaschiy vrach. 2020;(4):37. (In Russ.). https://doi.org/10.26295/OS.2020.29.10.007
  6. Adamyan LV, Aznaurova YaB. Molecular aspects of endometriosis. Problemy’ reprodukcii. 2015;21(2):66-77. (In Russ.). https://doi.org/10.17116/repro201521266-77
  7. Saunders PTK, Horne AW. Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell. 2021;184(11):2807-2824. https://doi.org/10.1016/j.cell.2021.04.041
  8. Xiang S, Li J, Shen J, Zhao Y, Wu X, Li M, Yang X, Kaboli PJ, Du F, Zheng Y, Wen Q, Cho CH, Yi T, Xiao Z. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Frontiers in Immunology. 2021;12:653836. https://doi.org/10.3389/fimmu.2021.653836
  9. Krechetova LV, Inviyaeva EV, Korotkova TD, Vanko LV, Adamyan LV. Features of the relationship between the subpopulation composition and the content of cytokines in the peripheral blood and peritoneal fluid of women with endometriosis. Problemy’ reprodukcii. 2023;29(1):19-32. (In Russ.). https://doi.org/10.17116/repro20232901119
  10. Adamyan LV, Aznaurova YaB. Biomarkers of endometriosis — current trends. Problemy reprodukcii. 2018;24(1):57-62. (In Russ.). https://doi.org/10.17116/repro201824157-62
  11. Korotkova TD, Adamyan LV, Stepanian AA, Krechetova LV, Vanko LV. Cellular and molecular factors of innate immunity in the pathogenesis of external genital endometriosis in women (a review). Problemy reproduktsii. 2018;24(6):22-31. (In Russ.). https://doi.org/10.17116/repro20182406122
  12. Zou G, Wang J, Xu X, Xu P, Zhu L, Yu Q, Peng Y, Guo X, Li T, Zhang X. Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing. Cell and Bioscience. 2021;11(1):98.  https://doi.org/10.1186/s13578-021-00613-5
  13. Wang L, Li L, Li Y, et al. A History of Endometriosis Is Associated With Decreased Peripheral NK Cytotoxicity and Increased Infiltration of Uterine CD68+ Macrophages. Frontiers in Immunology. 2021;12:711231. https://doi.org/10.3389/fimmu.2021.711231
  14. Zhong Q, Yang F, Chen X, Li J, Zhong C, Chen S. Patterns of Immune Infiltration in Endometriosis and Their Relationship to r-AFS Stages. Frontiers in Genetics. 2021;12:631715. https://doi.org/10.3389/fgene.2021.631715
  15. Fan D, Wang X, Shi Z, Jiang Y, Zheng B, Xu L, Zhou S. Understanding endometriosis from an immunomicroenvironmental perspective. Chinese Medical Journal. 2023;136(16):1897-1909. https://doi.org/10.1097/CM9.0000000000002649
  16. Miller JE, Ahn SH, Marks RM, Monsanto SP, Fazleabas AT, Koti M, Tayade C. IL-17A Modulates Peritoneal Macrophage Recruitment and M2 Polarization in Endometriosis. Frontiers in Immunology. 2020;11:108.  https://doi.org/10.3389/fimmu.2020.00108
  17. Lukács L, Kovács AR, Pál L, Szűcs S, Kövér Á, Lampé R. Phagocyte function of peripheral neutrophil granulocytes and monocytes in endometriosis before and after surgery. Journal of Gynecology Obstetrics and Human Reproduction. 2021;50(4):101796. https://doi.org/10.1016/j.jogoh.2020.101796
  18. Huang Q, Yu Y, Xu W, Li S, Zhou Y, Shu J. The Role of Peritoneal Immunity in Peritoneal Endometriosis and Related Infertility. Frontiers in Bioscience. 2023;28(8):166.  https://doi.org/10.31083/j.fbl2808166
  19. Adamyan LV, Manukyan LM, Loginova ON, Arslanyan KN, Zayratyants VO. The role of matrix metalloproteinases in the pathogenesis of endometriosis (literature review). Problemy reprodukcii. 2020;26(2):95-103. (In Russ.). https://doi.org/10.17116/repro20202602195
  20. Chopyak VV, Koval HD, Havrylyuk AM, Lishchuk-Yakymovych KA, Potomkina HA, Kurpisz MK. Immunopathogenesis of endometriosis — a novel look at an old problem. Central-European Journal of Immunology. 2022;47(1):109-116.  https://doi.org/10.5114/ceji.2022.113830
  21. Weng LC, Hou SH, Lei ST, Peng HY, Li MQ, Zhao D. Estrogen-regulated CD200 inhibits macrophage phagocytosis in endometriosis. Journal of Reproductive Immunology. 2020;138:103090. https://doi.org/10.1016/j.jri.2020.103090
  22. Liu YY, Liu YK, Hu WT, Tang LL, Sheng YR, Wei CY, Li MQ, Zhu XY. Elevated heme impairs macrophage phagocytosis in endometriosis. Reproduction. 2019;158(3):257-266.  https://doi.org/10.1530/REP-19-0028
  23. Abramiuk M, Grywalska E, Małkowska P, Sierawska O, Hrynkiewicz R, Niedźwiedzka-Rystwej P. The Role of the Immune System in the Development of Endometriosis. Cells. 2022;11(13):2028. https://doi.org/10.3390/cells11132028
  24. Martin P, Gurevich DB. Macrophage regulation of angiogenesis in health and disease. Seminars in Cell and Developmental Biology. 2021;119:101-110.  https://doi.org/10.1016/j.semcdb.2021.06.010
  25. Zairat’yants OV, Adamyan LV, Manukyan LM, Kalinin DV, Arslanyan KN. The expression of moesin, p21-activated kinase 4 (PAK 4), matrix metalloproteinases (MMP 2, MMP 9), and CD34 in the eutopic and ectopic endometrium in adenomyosis. Arkhiv patologii. 2018;80(6):14-21. (In Russ.). https://doi.org/10.17116/patol20188006114
  26. Burlev VA. Aberrant invasion of nervous fibers in endometriosis: the role of estrogens. Problemy’ reprodukcii. 2020;26(2):104-112. (In Russ.). https://doi.org/10.17116/repro202026021104
  27. Kogan EA, Ovakimian AS, Paramonova NB, Faĭzullina NM, Kazachenko IF, Adamyan LV. Morphological substrate and pathogenetic mechanisms of pelvic pain syndrome in endometriosis. Part II. Peripheral nerve tissue remodeling in the foci of endometriosis. Arkhiv patologii. 2016;78(3):20-25. (In Russ.). https://doi.org/10.17116/patol201678320-25
  28. Ansariniya H, Yavari A, Javaheri A, Zare F. Oxidative stress-related effects on various aspects of endometriosis. American Journal of Reproductive Immunology. 2022;88(3):E13593. https://doi.org/10.1111/aji.13593
  29. Adamyan LV, Sonova MM, Arslanyan KN, Loginova ON, Kharchenko EI. Oxidative stress and endometriosis: literature review. Lechaschiy vrach. 2019;(12):20-25. (In Russ.). https://doi.org/10.26295/OS.2019.72.92.003
  30. Yang HL, Zhou WJ, Chang KK, Mei J, Huang LQ, Wang MY, Meng Y, Ha SY, Li DJ, Li MQ. The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-β. Reproduction. 2017; 154(6):815-825.  https://doi.org/10.1530/REP-17-0342
  31. Lim CL, Lin VC. Estrogen markedly reduces circulating low-density neutrophils and enhances pro-tumoral gene expression in neutrophil of tumour-bearing mice. BMC Cancer. 2021;21(1):1017. https://doi.org/10.1186/s12885-021-08751-2
  32. Gardella B, Dominoni M, Gritti A, Arrigo A, Antonucci S, Carletti GV, Musacchi V, Pietrocola G. Endometriosis pain and epithelial neutrophil activating peptide-78 levels. Scientific Reports. 2022; 12(1):3227. https://doi.org/10.1038/s41598-022-07349-3
  33. Shi JL, Zheng ZM, Chen M, Shen HH, Li MQ, Shao J. IL-17: an important pathogenic factor in endometriosis. International Journal of Medical Sciences. 2022;19(4):769-778.  https://doi.org/10.7150/ijms.71972
  34. Olkowska-Truchanowicz J, Białoszewska A, Zwierzchowska A, Sztokfisz-Ignasiak A, Janiuk I, Dąbrowski F, Korczak-Kowalska G, Barcz E, Bocian K, Malejczyk J. Peritoneal Fluid from Patients with Ovarian Endometriosis Displays Immunosuppressive Potential and Stimulates Th2 Response. International Journal of Molecular Sciences. 2021;22(15):8134. https://doi.org/10.3390/ijms22158134
  35. Jiang Y, Wang L, Peng Y, Qin J, Tan A, Wang S. Interleukin 17 receptor E identifies heterogeneous T helper 17 cells in peritoneal fluid of moderate and severe endometriosis patients. Clinical and Experimental Immunology. 2022;207(3):360-369.  https://doi.org/10.1093/cei/uxac004
  36. Schmitz T, Hoffmann V, Olliges E, Bobinger A, Popovici R, Nößner E, Meissner K. Reduced frequency of perforin-positive CD8+ T cells in menstrual effluent of endometriosis patients. Journal of Reproductive Immunology. 2021;148:103424. https://doi.org/10.1016/j.jri.2021.103424
  37. Khan KN, Yamamoto K, Fujishita A, Muto H, Koshiba A, Kuroboshi H, Saito S, Teramukai S, Nakashima M, Kitawaki J. Differential Levels of Regulatory T Cells and T-Helper-17 Cells in Women With Early and Advanced Endometriosis. The Journal of Clinical Endocrinology and Metabolism. 2019;104(10):4715-4729. https://doi.org/10.1210/jc.2019-00350
  38. Ushiwaka T, Yamamoto S, Yoshii C, Hashimoto S, Tsuzuki T, Taniguchi K, Izumiya C, Kobayashi H, Maeda N. Peritoneal natural killer cell chemotaxis is decreased in women with pelvic endometriosis. American Journal of Reproductive Immunology. 2022;88(3): e13556. https://doi.org/10.1111/aji.13556
  39. Xu H. Expressions of natural cytotoxicity receptor, NKG2D and NKG2D ligands in endometriosis. Journal of Reproductive Immunology. 2019;136:102615. https://doi.org/10.1016/j.jri.2019.102615
  40. Du Y, Liu X, Guo SW. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms. Human Reproduction. 2017;32(4):794-810.  https://doi.org/10.1093/humrep/dex014
  41. Louwen F, Kreis NN, Ritter A, Friemel A, Solbach C, Yuan J. BCL6, a key oncogene, in the placenta, pre-eclampsia and endometriosis. Human Reproduction Update. 2022;28(6):890-909.  https://doi.org/10.1093/humupd/dmac027
  42. Ovakimyan AS, Krechetova LV, Vtorushina VV, Van’ko LV, Kozachenko IF, Yarotskaya EL, Adamyan LV. The content of interleukin1β, interleukin-8 and substance P in the blood plasma and peritoneal fluid of patients with various forms of external genital endometriosis and chronic pelvic pain. Akusherstvo i ginekologiya. 2015; 3:79-86. (In Russ.). https://doi.org/10.1016/j.jmig.2015.08.634
  43. Song Y, Su RW, Joshi NR, Kim TH, Lessey BA, Jeong JW, Fazleabas AT. Interleukin-6 (IL-6) Activates the NOTCH1 Signaling Pathway through E-Proteins in Endometriotic Lesions. The Journal of Clinical Endocrinology and Metabolism. 2020;105(5):1316-1326. https://doi.org/10.1210/clinem/dgaa096
  44. Krasnyi AM, Sadekova AA, Sefihanov TG, Vtorushina VV, Krechetova EG, Khilkevich EG, Arakelyan AS, Pavlovich SV. The content of cytokines IL-6, IL-8, TNF-α, IL-4 and the level of expression in macrophages CD86 and CD163 in peritoneal fluid has a reverse correlation with the degree of severity of external genital endometriosis. Biomeditsinskaia khimiia. 2019;65(5):432-436. (In Russ.). https://doi.org/10.18097/PBMC20196505432
  45. Koninckx PR, Ussia A, Adamyan L. The role of the peritoneal cavity in adhesion formation. Fertility and Sterility. 2012;97(6):1297. https://doi.org/10.1016/j.fertnstert.2012.04.017
  46. Adamyan LV, Sonova MM, Arslanyan KN, Loginova ON. The role of cytokines in the clinical presentation of external genital endometriosis and chronic pelvic pain. Voprosy ginekologii, akusherstva i perinatologii. 2020;19(1):5-11. (In Russ.). https://doi.org/10.20953/1726-1678-2020-1-5-11
  47. Nisenblat V, Sharkey DJ, Wang Z, Evans SF, Healey M, Ohlsson Teague EMC, Print CG, Robertson SA, Hull ML. Plasma miRNAs Display Limited Potential as Diagnostic Tools for Endometriosis. Plasma miRNAs Display Limited Potential as Diagnostic Tools for Endometriosis. The Journal of Clinical Endocrinology and Metabolism. 2019;104(6):1999-2022. https://doi.org/10.1210/jc.2018-01464
  48. Anastasiu CV, Moga MA, Elena Neculau A, Bălan A, Scârneciu I, Dragomir RM, Dull AM, Chicea LM. Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives. International Journal of Molecular Sciences. 2020;21(5):1750. https://doi.org/10.3390/ijms21051750
  49. Irungu S, Mavrelos D, Worthington J, Blyuss O, Saridogan E, Timms JF. Discovery of non-invasive biomarkers for the diagnosis of endometriosis. Clinical Proteomics. 2019;16:14.  https://doi.org/10.1186/s12014-019-9235-3
  50. McCallion A, Sisnett D J, Zutautas K B, Hayati D, Spiess K G, Aleksieva S, Lingegowda H, Koti M. Chandrakant Tayade Endometriosis through an immunological lens: a pathophysiology based in immune dysregulation. Exploration of Immunology. 2022;2:454-483.  https://doi.org/10.37349/ei.2022.00062
  51. Kovács Z, Glover L, Reidy F, MacSharry J, Saldova R. Novel diagnostic options for endometriosis — Based on the glycome and microbiome. Journal of Advanced Research. 2021;33:167-181.  https://doi.org/10.1016/j.jare.2021.01.015
  52. Choi YS, Kim S, Oh YS, Cho S, Hoon Kim S. Elevated serum interleukin-32 levels in patients with endometriosis: A cross-sectional study. American Journal of Reproductive Immunology. 2019;82(2): e13149. https://doi.org/10.1111/aji.13149
  53. Johannes L, Jacob R, Leffler H. Galectins at a glance. Journal of Cell Science. 2018;131(9):jcs208884. https://doi.org/10.1242/jcs.208884
  54. Hisrich BV, Young RB, Sansone AM, Bowens Z, Green LJ, Lessey BA. Role of human galectins in inflammation and cancers associated with endometriosis. Biomolecules. 2020;10 (2):230.  https://doi.org/10.3390/biom10020230
  55. Brubel R, Bokor A, Pohl A, Schilli GK, Szereday L, Bacher-Szamuel R, Rigo J, Polgar B. Serum galectin-9 as a noninvasive biomarker for the detection of endometriosis and pelvic pain or infertility-related gynecologic disorders. Fertility and Sterility. 2017; 108(6):1016-1025 e2.  https://doi.org/10.1016/j.fertnstert.2017.09.008
  56. Shigesi N, Kvaskoff M, Kirtley S, Feng Q, Fang H, Knight JC. The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis. Human Reproduction Update. 2019;25(4):486-503.  https://doi.org/10.1093/humupd/dmz014
  57. Greenbaum H, Galper B-E L, Decter D H, Eisenberg VH. Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool? Autoimmunity Reviews. 2021;20(5): 102795. https://doi.org/10.1016/j.autrev.2021.102795
  58. Gajbhiye R, Bendigeri T, Ghuge A, Bhusane K, Begum S, Warty N. Panel of Autoimmune Markers for Noninvasive Diagnosis of Minimal-Mild Endometriosis. Reproductive Sciences. 2017;24(3):413-420.  https://doi.org/10.1177/1933719116657190
  59. Zhang L, Li H, Yuan M, Li D, Sun C, Wang G. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis. Disease Markers. 2020;23:2456340. https://doi.org/10.1155/2020/2456340
  60. Vanhie A, Peterse DOD, Beckers A, Cuellar A, Fassbender A, Meuleman C, Mestdagh P, D’Hooghe T. Plasma miRNAs as biomarkers for endometriosis. Human Reproduction. 2019;34:1650-1660. https://doi.org/10.1093/humrep/dez116
  61. Maged AM, Deeb WS, El Amir A, Zaki SS, El Sawah H, Al Mohamady M, Metwally AA, Katta MA. Diagnostic accuracy of serum miR-122 and miR-199a in women with endometriosis. International Journal of Gynecology and Obstetrics. 2017;141(1):14-19.  https://doi.org/10.1002/ijgo.12392
  62. Papari E, Noruzinia M, Kashani L, Foster WG. Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction. Fertility and Sterility. 2020;113(6):1232-1241. https://doi.org/10.1016/j.fertnstert.2020.01.026
  63. Wang W-T, Sun Y-M, Huang W, He B, Zhao Y-N, Chen Y-Q. Genome-wide long non-coding RNA. Analysis identified circulating LncRNAs as novel non-invasive diagnostic biomarkers for gynecological disease. Scientific Reports. 2016;6:23343.
  64. Zhang XY, Zheng LW, Li CJ, Xu Y, Zhou X, Fu LL, Li DD, Sun LT, Zhang D, Cui MH. Dysregulated Expression of Long Noncoding RNAs in Endometriosis. Critical Reviews in Eukaryotic Gene Expression. 2019;29(2):113-121.  https://doi.org/10.1615/CritRevEukaryotGeneExpr.2019026460
  65. Qiu J, Zhang X, Ding Y, Hua K. 1856 circulating exosomal long noncoding RNA-TC0101441 as a non-invasive biomarker for the prediction of endometriosis severity and recurrence. Journal of Minimally Invasive Gynecology. 2019;26:170-171.  https://doi.org/10.1016/j.jmig.2019.09.309
  66. Alonso A, Yuwono N L, Houshdaran S, Abbott J, Rodgers R, Ford CE, Warton K. Comparison of total and endometrial circulating cell-free DNA in women with and without endometriosis. Reproductive BioMedicine Online. 2022;44(3):495-503.  https://doi.org/10.1016/j.rbmo.2021.11.006
  67. Yuwono N L, Alonso A, Abbott J, Houshdaran S, Henry CE. Circulating cell-free endometrial DNA level is unaltered during menstruation and in endometriosis. Human Reproduction. 2022;37(11): 2560-2569. https://doi.org/10.1093/humrep/deac198
  68. Creed J, Maggrah A, Reguly B, Harbottle A. Mitochondrial DNA deletions accurately detect endometriosis in symptomatic females of child-bearing age. Biomarkers in Medicine. 2019;13(4):291-306.  https://doi.org/10.2217/bmm-2018-0419
  69. Greenbaum H, Galper BL, Decter DH, Eisenberg VH. Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool? Autoimmunity Reviews. 2021;20(5): 102795. https://doi.org/10.1016/j.autrev.2021.102795
  70. Maksym RB, Hoffmann-Młodzianowska M, Skibińska M, Rabijewski M, Mackiewicz A, Kieda C. Immunology and Immunotherapy of Endometriosis. Journal of Clinical Medicine. 2021;10(24):5879. https://doi.org/10.3390/jcm10245879
  71. Yoshii E, Yamana H, Ono S, Matsui H, Yasunaga H. Association between allergic or autoimmune diseases and incidence of endometriosis: A nested case-control study using a health insurance claims database. American Journal of Reproductive Immunology. 2021;86(5): e13486. https://doi.org/10.1111/aji.13486
  72. Zizolfi B, Foreste V, Bonavita S, Rubino V, Ruggiero G, Brescia Morra V, Lanzillo R, Carotenuto A, Boscia F, Taglialatela M, Guida M. Epidemiological and Immune Profile Analysis of Italian Subjects with Endometriosis and Multiple Sclerosis. Journal of Clinical Medicine. 2023;12(5):2043. https://doi.org/10.3390/jcm12052043
  73. Chao YH, Liu CH, Pan YA, Yen FS, Chiou JY, Wei JC. Association between Endometriosis and Subsequent Risk of Sjögren’s Syndrome: A Nationwide Population-Based Cohort Study. Frontiers in Immunology. 2022;13:845944. https://doi.org/10.3389/fimmu.2022.845944
  74. Ríos-Ríos WJ, Sosa-Luis SA, Torres-Aguilar H. T Cells Subsets in the Immunopathology and Treatment of Sjogren’s Syndrome. Biomolecules. 2020;10(11):1539. https://doi.org/10.3390/biom10111539
  75. Zervou MI, Tarlatzis BC, Grimbizis GF, Spandidos DA, Niewold TB, Goulielmos GN. Association of endometriosis with Sjögren’s syndrome: Genetic insights (Review). International Journal of Molecular Medicine. 2024;53(2):20.  https://doi.org/10.3892/ijmm.2024.5344
  76. Adamyan LV, Osipova AA, Aznaurova YaB, Sonova MM, Petrov IV, Suntsova MV, Buzdin AA. Analysis of gene expression and activation of signalling pathways in eutopic and ectopic endometrium of patients with external genital endometriosis. Voprosy ginekologii, akusherstva i perinatologii. 2019;18(1):6-10. (In Russ.). https://doi.org/10.20953/1726-1678-2019-1-6-10
  77. Rahmioglu N, Mortlock S, Ghiasi M, Møller PL, Stefansdottir L, Galarneau G, Turman C, Danning R, Law MH, Sapkota Y, Christofidou P, Skarp S, Giri A, Banasik K, Krassowski M, Lepamets M, Marciniak B, Nõukas M, Perro D, Sliz E, Sobalska-Kwapis M, Thorleifsson G, Topbas-Selcuki NF, Vitonis A, Westergaard D, Arnadottir R, Burgdorf KS, Campbell A, Cheuk CSK, Clementi C, Cook J, De Vivo I, DiVasta A, Dorien O, Donoghue JF, Edwards T, Fontanillas P, Fung JN, Geirsson RT, Girling JE, Harkki P, Harris HR, Healey M, Heikinheimo O, Holdsworth-Carson S, Hostettler IC, Houlden H, Houshdaran S, Irwin JC, Jarvelin MR, Kamatani Y, Kennedy SH, Kepka E, Kettunen J, Kubo M, Kulig B, Kurra V, Laivuori H, Laufer MR, Lindgren CM, MacGregor S, Mangino M, Martin NG, Matalliotaki C, Matalliotakis M, Murray AD, Ndungu A, Nezhat C, Olsen CM, Opoku-Anane J, Padmanabhan S, Paranjpe M, Peters M, Polak G, Porteous DJ, Rabban J, Rexrode KM, Romanowicz H, Saare M, Saavalainen L, Schork AJ, Sen S, Shafrir AL, Siewierska-Górska A, Słomka M, Smith BH, Smolarz B, Szaflik T, Szyłło K, Takahashi A, Terry KL, Tomassetti C, Treloar SA, Vanhie A, Vincent K, Vo KC, Werring DJ, Zeggini E, Zervou MI; DBDS Genomic Consortium; FinnGen Study; FinnGen Endometriosis Taskforce; Celmatix Research Team; 23 and Me Research Team; Adachi S, Buring JE, Ridker PM, D’Hooghe T, Goulielmos GN, Hapangama DK, Hayward C, Horne AW, Low SK, Martikainen H, Chasman DI, Rogers PAW, Saunders PT, Sirota M, Spector T, Strapagiel D, Tung JY, Whiteman DC, Giudice LC, Velez-Edwards DR, Uimari O, Kraft P, Salumets A, Nyholt DR, Mägi R, Stefansson K, Becker CM, Yurttas-Beim P, Steinthorsdottir V, Nyegaard M, Missmer SA, Montgomery GW, Morris AP, Zondervan KT. The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions. Nature Genetics. 2023;55(3):423-436.  https://doi.org/10.1038/s41588-023-01323-z
  78. Bianco B, Fernandes RFM, Trevisan CM, Christofolini DM, Sanz-Lomana CM, de Bernabe JV, Barbosa CP. Influence of STAT4 gene polymorphisms in the pathogenesis of endometriosis. Annals of Human Genetics. 2019;83(4):249-255.  https://doi.org/10.1111/ahg.12309
  79. Xue YH, You LT, Ting HF, Chen YW, Sheng ZY, Xie YD, Wang YH, Chiou JY, Wei JC. Increased risk of rheumatoid arthritis among patients with endometriosis: a nationwide population-based cohort study. Rheumatology. 2021;60(7):3326-3333. https://doi.org/10.1093/rheumatology/keaa784
  80. Chen SF, Yang YC, Hsu CY, Shen YC. Risk of Rheumatoid Arthritis in Patients with Endometriosis: A Nationwide Population-Based Cohort Study. Journal of Women’s Health. 2021;30(8):1160-1164. https://doi.org/10.1089/jwh.2020.8431
  81. Coskun Benlidayi I. Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatology International. 2019;39(5): 781-791.  https://doi.org/10.1007/s00296-019-04251-6
  82. Hamouda RK, Arzoun H, Sahib I, Escudero Mendez L, Srinivasan M, Shoukrie SI, Dhanoa RK, Selvaraj R, Malla J, Selvamani TY, Zahra A, Venugopal S, Mohammed L. The Comorbidity of Endometriosis and Systemic Lupus Erythematosus: A Systematic Review. Cureus. 2023;15(7):e42362. https://doi.org/10.7759/cureus.42362
  83. Sun YH, Leong PY, Huang JY, Wei JC. Increased risk of being diagnosed with endometriosis in patients with Systemic lupus erythematosus: a population-based cohort study in Taiwan. Scientific Reports. 2022;12(1):13336. https://doi.org/10.1038/s41598-022-17343-4
  84. Dang Y, Zhang S. Causal relationship between endometriosis and inflammatory bowel disease: A Mendelian randomization analyses. Clinical and Translational Medicine. 2024;14(1):e1496. https://doi.org/10.1002/ctm2.1496
  85. Narula N, Wong ECL, Pray C, Marshall JK, Rangarajan S, Islam S, Bahonar A, Alhabib KF, Kontsevaya A, Ariffin F, Co HU, Al Sharief W, Szuba A, Wielgosz A, Diaz ML, Yusuf R, Kruger L, Soman B, Li Y, Wang C, Yin L, Mirrakhimov E, Lanas F, Davletov K, Rosengren A, Lopez-Jaramillo P, Khatib R, Oguz A, Iqbal R, Yeates K, Avezum Á, Reinisch W, Moayyedi P, Yusuf S. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study. Clinical Gastroenterology and Hepatology. 2023;21(10):2649-2659.e16.  https://doi.org/10.1016/j.cgh.2022.11.037
  86. Li J, Yan S, Li Q, Huang Y, Ji M, Jiao X, Yuan M, Wang G. Macrophage-associated immune checkpoint CD47 blocking ameliorates endometriosis. Molecular Human Reproduction. 2022;28(5):gaac010. https://doi.org/10.1093/molehr/gaac010
  87. Vallée A, Lecarpentier Y. Curcumin and Endometriosis. International Journal of Molecular Sciences. 2020;21(7):2440. https://doi.org/10.3390/ijms21072440
  88. Hoogstad-van Evert J, Paap R, Nap A, van der Molen R. The Promises of Natural Killer Cell Therapy in Endometriosis. International Journal of Molecular Sciences. 2022;23(10):5539. https://doi.org/10.3390/ijms23105539
  89. Önalan G, Tohma YA, Zeyneloğlu HB. Effect of Etanercept on the Success of Assisted Reproductive Technology in Patients with Endometrioma. Gynecologic and Obstetric Investigation. 2018;83(4):358-364.  https://doi.org/10.1159/000484895
  90. Park Y, Cho YJ, Sung N, Park MJ, Guan X, Gibbons WE, O’Malley BW, Han SJ. Oleuropein suppresses endometriosis progression and improves the fertility of mice with endometriosis. Journal of Biomedical Science. 2022;29(1):100.  https://doi.org/10.1186/s12929-022-00883-2
  91. https://doi.org/10.17816/JOWD68147-58  https://doi.org/10.17816/JOWD68147-58
  92. Park Y, Han SJ. Interferon Signaling in the Endometrium and in Endometriosis. Biomolecules. 2022;12(11):1554. https://doi.org/10.3390/biom12111554
  93. Dicitore A, Castiglioni S, Saronni D, Gentilini D, Borghi MO, Stabile S, Vignali M, Di Blasio AM, Persani L, Vitale G. Effects of human recombinant type I IFNs (IFN-α2b and IFN-β1a) on growth and migration of primary endometrial stromal cells from women with deeply infiltrating endometriosis: A preliminary study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2018; 230:192-198.  https://doi.org/10.1016/j.ejogrb.2018.10.004
  94. Wu C, Ma J, Yang H, Zhang J, Sun C, Lei Y, Liu M, Cao J. Interleukin-37 as a biomarker of mortality risk in patients with sepsis. The Journal of Infection. 2021;82(3):346-354.  https://doi.org/10.1016/j.jinf.2021.01.019
  95. He Y, Xiong T, Guo F, Du Z, Fan Y, Sun H, Feng Z, Zhang G. Interleukin-37b inhibits the growth of murine endometriosis-like lesions by regulating proliferation, invasion, angiogenesis and inflammation. Molecular Human Reproduction. 2020;26(4):240-255.  https://doi.org/10.1093/molehr/gaaa014
  96. Li L, Liao Z, Ye M, Jiang J. Recombinant human IL-37 inhibited endometriosis development in a mouse model through increasing Th1/Th2 ratio by inducing the maturation of dendritic cells. Reproductive Biology and Endocrinology. 2021;19(1):128.  https://doi.org/10.1186/s12958-021-00811-3
  97. Kato T, Yasuda K, Matsushita K, Ishii KJ, Hirota S, Yoshimoto T, Shibahara H. Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis. Frontiers in Immunology. 2019;10:2021. https://doi.org/10.3389/fimmu.2019.02021
  98. Miller JE, Lingegowda H, Symons LK, Bougie O, Young SL, Lessey BA, Koti M, Tayade C. IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis. JCI Insight. 2021;6(23): e149699. https://doi.org/10.1172/jci.insight.149699
  99. Hecht J, Suliman S, Wegiel B. Bacillus Calmette-Guerin (BCG) vaccination to treat endometriosis. Vaccine. 2021;39(50):7353-7356. https://doi.org/10.1016/j.vaccine.2021.07.020
  100. Dera-Szymanowska A, Chmaj-Wierzchowska K, Horst N, Stryjakowska K, Wirlstein P, Andrusiewicz M, Florek E, Beltrano J, Szymanowski K, Wolun-Cholewa M. Immunomodulation inhibits the development of endometriosis in rats. Journal of Physiology and Pharmacology. 2020;71(1):10.26402/jpp.2020.1.14.  https://doi.org/10.26402/jpp.2020.1.14
  101. Somigliana E, Sarais V, Reschini M, Ferrari S, Makieva S, Cermisoni GC, Paffoni A, Papaleo E, Vigano P. Single oral dose of vitamin D3 supplementation prior to in vitro fertilization and embryo transfer in normal weight women: the SUNDRO randomized controlled trial. American Journal of Obstetrics and Gynecology. 2021;225(3):283.e1-283.e10.  https://doi.org/10.1016/j.ajog.2021.04.234
  102. Zhao SS, Fang S, Zhu CY, Wang LL, Gao CJ. [Effect of G-CSF in vitro Stimulation on Distribution of Peripheral Lymphocyte Subsets in the Healthy Persons]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018;26(1):258-262.  https://doi.org/10.7534/j.issn.1009-2137.2018.01.045
  103. Ding J, Wang J, Cai X, Yin T, Zhang Y, Yang C, Yang J. Granulocyte colony-stimulating factor in reproductive-related disease: Function, regulation and therapeutic effect. Biomedicine and Pharmacotherapy. 2022;150:112903. https://doi.org/10.1016/j.biopha.2022.112903
  104. Huang P, Yao C, Wei L, Lin Z. The intrauterine perfusion of granulocyte-colony stimulating factor (G-CSF) before frozen-thawed embryo transfer in patients with two or more implantation failures. Human Fertility. 2020;31:1811904. https://doi.org/10.1080/14647273.2020.1811904
  105. Chen P, Mamillapalli R, Habata S, Taylor HS. Endometriosis stromal cells induce bone marrow mesenchymal stem cell differentiation and PD-1 expression through paracrine signaling. Molecular and Cellular Biochemistry. 2021;476(4):1717-1727. https://doi.org/10.1007/s11010-020-04012-1
  106. Kamath MS, Kirubakaran R, Sunkara SK. Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction. The Cochrane Database of Systematic Reviews. 2020;1(1):CD013226. https://doi.org/10.1002/14651858.CD013226.pub2
  107. Li T, Mamillapalli R, Ding S, Chang H, Liu ZW, Gao XB, Taylor HS. Endometriosis alters brain electro-physiology, gene expression and increased pain sensitization, anxiety, and depression in female mice. Biology of Reproduction. 2018;99(2):349-359.  https://doi.org/10.1093/biolre/ioy035
  108. Forster R, Sarginson A, Velichkova A, Hogg C, Dorning A, Horne AW, Saunders PTK, Greaves E. Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis. FASEB Journal. 2019; 33(10):11210-11222. https://doi.org/10.1096/fj.201900797R
  109. D’Hooghe TM, Vanhie A, Flores VA, Taylor HS. Macrophage depletion: a potential immunomodulator treatment of endometriosis-associated pain? Annals of Translational Medicine. 2020;8(22):1534. https://doi.org/10.21037/atm-2020-98
  110. Riccio LGC, Jeljeli M, Santulli P, Chouzenoux S, Doridot L, Nicco C, Reis FM, Abrão MS, Chapron C, Batteux F. B lymphocytes inactivation by Ibrutinib limits endometriosis progression in mice. Human Reproduction. 2019;34(7):1225-1234. https://doi.org/10.1093/humrep/dez071
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.